Zoetis (ZTS)
(Delayed Data from NYSE)
$174.06 USD
+0.35 (0.20%)
Updated May 17, 2024 03:59 PM ET
After-Market: $173.99 -0.07 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ZTS 174.06 +0.35(0.20%)
Will ZTS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ZTS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZTS
Is Trending Stock Zoetis Inc. (ZTS) a Buy Now?
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
ZTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Zoetis (ZTS) Q1 Earnings: A Look at Key Metrics
Zoetis (ZTS) Beats Q1 Earnings and Revenue Estimates
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Other News for ZTS
Positive Long-Term Growth Forecast for Zoetis with Strong Product Adoption and Robust Franchise Performance
Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference
Aristotle Capital Core Equity Q1 2024 Commentary
Paul Tudor Jones Adjusts Portfolio, Major Reduction in NVIDIA Amidst Strategic Shifts
Zoetis Named a Top Company for DE&I by Fair360 (Formerly DiversityInc.)